SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-056988
Filing Date
2005-11-21
Accepted
2005-11-21 14:57:41
Documents
3
Period of Report
2005-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a05-20708_18k.htm 8-K 29565
2 EXHIBIT 99 a05-20708_1ex99d1.htm EX-99.1 20779
3 GRAPHIC g207081mmi001.gif GRAPHIC 6078
  Complete submission text file 0001104659-05-056988.txt   60573
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 051217731
SIC: 2835 In Vitro & In Vivo Diagnostic Substances